Finance

Lists
CLN:WSE
Celon Pharma SA
19,00 PLN
+0,85%
(+0,16) 1D
6 ოქტ, 17:04:20 GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for CLN...
Open
18,84 PLN
High
19,14 PLN
Low
18,66 PLN
Mkt. cap
1,02 მლრდ.
Avg. vol.
17,16 ათ.
Volume
11,21 ათ.
P/E ratio
9,26
52-wk high
23,50 PLN
52-wk low
18,00 PLN
EPS
2,05 PLN
Shares outstanding
53,91 მლნ.
No. of employees
560
Open
18,84 PLN
High
19,14 PLN
Low
18,66 PLN
Mkt. cap
1,02 მლრდ.
Avg. vol.
17,16 ათ.
Volume
11,21 ათ.
P/E ratio
9,26
52-wk high
23,50 PLN
52-wk low
18,00 PLN
EPS
2,05 PLN
Shares outstanding
53,91 მლნ.
No. of employees
560
News stories
From web sources and news partners
About Celon Pharma SA
CEO-
Employees560
Founded2002
Headquarters-
SectorPharmaceutical industry
Websitecelonpharma.com
Last report
16 სექ. 2026
Fiscal period
Q2 2026
EPS / Est. (PLN)
- / -
Revenue / Est. (PLN)
55,57 მლნ. / 60,50 მლნ.
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
71,13 მლნ.
66,67 მლნ.
65,26 მლნ.
55,57 მლნ.
Cost of goods sold
16,83 მლნ.
11,54 მლნ.
16,70 მლნ.
14,92 მლნ.
Cost of revenue
16,83 მლნ.
11,54 მლნ.
16,70 მლნ.
14,92 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33,02 მლნ.
35,44 მლნ.
36,08 მლნ.
38,62 მლნ.
Operating expense
46,24 მლნ.
52,60 მლნ.
54,54 მლნ.
50,11 მლნ.
Total operating expenses
63,07 მლნ.
64,14 მლნ.
71,23 მლნ.
65,04 მლნ.
Operating income
8,06 მლნ.
2,53 მლნ.
-5,98 მლნ.
-9,46 მლნ.
Other non operating income
-30,00 ათ.
-250,00 ათ.
169,05 მლნ.
3,48 მლნ.
EBT including unusual items
-2,77 მლნ.
-6,57 მლნ.
160,34 მლნ.
-7,38 მლნ.
EBT excluding unusual items
-2,77 მლნ.
-6,57 მლნ.
160,34 მლნ.
-7,38 მლნ.
Income tax expense
-6,43 მლნ.
18,33 მლნ.
1,70 მლნ.
23,21 მლნ.
Effective tax rate
232,29%
-279,14%
1,06%
-314,48%
Other operating expenses
2,20 მლნ.
6,37 მლნ.
7,33 მლნ.
1,36 მლნ.
Net income
3,66 მლნ.
-24,90 მლნ.
158,64 მლნ.
-30,59 მლნ.
Net profit margin
5,15%
-37,35%
243,09%
-55,05%
Earnings per share
-
-
-
-
Interest and investment income
-
149,00 ათ.
151,00 ათ.
151,00 ათ.
Interest expense
-
-341,00 ათ.
-915,00 ათ.
-1,55 მლნ.
Net interest expenses
-
-192,00 ათ.
-764,00 ათ.
-1,40 მლნ.
Depreciation and amortization charges
11,01 მლნ.
10,78 მლნ.
11,13 მლნ.
10,13 მლნ.
EBITDA
16,34 მლნ.
11,40 მლნ.
3,44 მლნ.
-748,00 ათ.
Gain or loss from assets sale
-170,00 ათ.
-2,91 მლნ.
-569,00 ათ.
716,00 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები